The Practice of Pre-Marketing Safety Assessment in Drug Development

Author： Chuang-Stein Christy   Xia H. Amy  

Publisher： Taylor & Francis Ltd

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.23, Iss.1, 2013-01, pp. : 3-25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Safety Profile of Sildenafil in Singaporean Men with Erectile Dysfunction: Pre-marketing Experience (ASSESS-I Evaluation)

By Lim PHC   Ng FC   Cheng CWS   Wong MYC   Chee CTY   Moorthy P   Vasan SS  

The Journal of International Medical Research, Vol. 30, Iss. 2, 2002-03 ,pp. : 137-143

Field House Publishing

Access to resources Recommend Favorite

Cardiovascular Safety Profile of Dapoxetine during the Premarketing Evaluation

By Kowey Peter R.  

Drugs in R&D, Vol. 11, Iss. 1, 2011-03 ,pp. : 1-11

Adis International

Access to resources Recommend Favorite

Toxicogenomics in drug safety assessment

By Hewitt Philip   Walijew Alexandra  

Pharmacogenomics, Vol. 9, Iss. 4, 2008-04 ,pp. : 379-382

Future Medicine

Access to resources Recommend Favorite

Pharma marketing techniques might improve drug safety

By  

Reactions Weekly, Vol. 1, Iss. 1232, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Zebrafish Model in Drug Safety Assessment

By  

Current Pharmaceutical Design, Vol. 20, Iss. 34, 2014-10 ,pp. : 5416-5429

Bentham Science Publishers

Access to resources Recommend Favorite